Search alternatives:
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 19,381 - 19,400 results of 74,781 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 1.36s Refine Results
  1. 19381
    Effects of functionalized multi-walled carbon nanotubes on toxicity and bioaccumulation of lead in <i>Daphnia magna</i>

    Effects of functionalized multi-walled carbon nanotubes on toxicity and bioaccumulation of lead in <i>Daphnia magna</i> by Min-Hee Jang (827908)

    Published 2018
    “…The negatively charged C-MWCNT showed a notable decrease in lead toxicity (LC<sub>50</sub> value increased from 0.15 mg L<sup>-1</sup> to 1.08 mg L<sup>-1</sup> in the presence of 10 mg L<sup>-1</sup> C-MWCNT), whereas the positively charged N-MWCNT had only a slight effect on lead toxicity (LC<sub>50</sub> value increased from 0.15 mg L<sup>-1</sup> to 0.16 mg L<sup>-1</sup> in the presence of 10 mg L<sup>-1</sup> N-MWCNT). …”
    Save to List
    Saved in:
  2. 19382
    Image_3_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_3_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  3. 19383
    Image_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  4. 19384
    Image_4_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_4_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  5. 19385
    Image_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  6. 19386
    Image_2_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_2_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  7. 19387
    Image_2_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_2_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  8. 19388
    Image_4_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_4_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  9. 19389
    Table5_The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China.DOCX

    Table5_The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China.DOCX by Mingfen Wu (11894288)

    Published 2024
    Save to List
    Saved in:
  10. 19390
    Image_3_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg

    Image_3_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.jpeg by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  11. 19391
    PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells

    PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells by Emmanouella Tsirimonaki (490707)

    Published 2013
    “…More importantly, ψεRACK induced upregulation of hsa-miR-377 expression, coupled to decreases in <i>ADAMTS5</i> and cleaved aggrecan. Therefore, PKCε activation in late passage NP cells may represent a molecular basis for aggrecan availability, as part of an PKCε/ERK/CREB/AP-1-dependent transcriptional program that includes upregulation of both chondrogenic genes and microRNAs. …”
    Save to List
    Saved in:
  12. 19392
    Table_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.xlsx

    Table_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.xlsx by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  13. 19393
    Presentation5_ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation.PPTX

    Presentation5_ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation.PPTX by Dongxin Chen (12215954)

    Published 2022
    Save to List
    Saved in:
  14. 19394
    Table_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.xlsx

    Table_1_Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.xlsx by Aracelly Gaete-Argel (9560644)

    Published 2023
    “…</p>Methods<p>We designed a prospective, open-label, observational clinical cohort study. 45 participants received two doses of BNT162b2 or CoronaVac (21-day or 28-day intervals, respectively) followed by a first and second booster with BNT162b2 (5-month apart each) and we analyzed the neutralizing antibody titers against SARSCoV-2 D614G (B.1 lineage) and Omicron (BA.1 lineage).…”
    Save to List
    Saved in:
  15. 19395
    A Recyclable, Immobilized Analogue of Benzotetramisole for Catalytic Enantioselective Domino Michael Addition/Cyclization Reactions in Batch and Flow

    A Recyclable, Immobilized Analogue of Benzotetramisole for Catalytic Enantioselective Domino Michael Addition/Cyclization Reactions in Batch and Flow by Javier Izquierdo (1333773)

    Published 2016
    “…A polystyrene-supported, enantiopure benzotetramisole (BTM) analogue (<b>5</b>) has been synthesized from (2<i>S</i>,3<i>S</i>)-phenylglycidol through a five-step sequence involving a copper-catalyzed alkyne azide cycloaddition (CuAAC) reaction as the final, immobilization step. …”
    Save to List
    Saved in:
  16. 19396
    A Recyclable, Immobilized Analogue of Benzotetramisole for Catalytic Enantioselective Domino Michael Addition/Cyclization Reactions in Batch and Flow

    A Recyclable, Immobilized Analogue of Benzotetramisole for Catalytic Enantioselective Domino Michael Addition/Cyclization Reactions in Batch and Flow by Javier Izquierdo (1333773)

    Published 2016
    “…A polystyrene-supported, enantiopure benzotetramisole (BTM) analogue (<b>5</b>) has been synthesized from (2<i>S</i>,3<i>S</i>)-phenylglycidol through a five-step sequence involving a copper-catalyzed alkyne azide cycloaddition (CuAAC) reaction as the final, immobilization step. …”
    Save to List
    Saved in:
  17. 19397
    A Recyclable, Immobilized Analogue of Benzotetramisole for Catalytic Enantioselective Domino Michael Addition/Cyclization Reactions in Batch and Flow

    A Recyclable, Immobilized Analogue of Benzotetramisole for Catalytic Enantioselective Domino Michael Addition/Cyclization Reactions in Batch and Flow by Javier Izquierdo (1333773)

    Published 2016
    “…A polystyrene-supported, enantiopure benzotetramisole (BTM) analogue (<b>5</b>) has been synthesized from (2<i>S</i>,3<i>S</i>)-phenylglycidol through a five-step sequence involving a copper-catalyzed alkyne azide cycloaddition (CuAAC) reaction as the final, immobilization step. …”
    Save to List
    Saved in:
  18. 19398
    Average relative abundance of the 6 main taxa in undiluted saliva and dilutions 1 to 3 (10<sup>7</sup> to 10<sup>5</sup> bacteria per ml, respectively).

    Average relative abundance of the 6 main taxa in undiluted saliva and dilutions 1 to 3 (10<sup>7</sup> to 10<sup>5</sup> bacteria per ml, respectively). by Giske Biesbroek (104538)

    Published 2012
    “…Dilution 3 shows a significant increase in Proteobacteria (p<0.001, mean 26,11% and 3.6%, SD 17.5 and 2.5% respectively) and a significant decrease in Bacteroidetes (p<0.001, mean 18.99% and 43.1% respectively) compared to the undiluted saliva samples. …”
    Save to List
    Saved in:
  19. 19399
    Image_5_A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.tif

    Image_5_A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.tif by Yuanyuan Wang (20181)

    Published 2021
    Save to List
    Saved in:
  20. 19400
    Hypoxic MSCs maintain stemness properties.

    Hypoxic MSCs maintain stemness properties. by Rohini L. Kadle (4919335)

    Published 2018
    Save to List
    Saved in:

Search Tools: